Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Recently recognized as a rare complication of adenoviral vector-based COVID-19 vaccines, VITT is marked by the presence of high-titer anti-PF4 antibodies. This evidence concerns the gene PF4 and COVID-19.